Block of P2X7 receptors could partly reverse the delayed neuronal death in area CA1 of the hippocampus after transient global cerebral ischemia

• DOI: 10.1007/s11302-013-9379-y
• Publication Date: 2013-07-22T18:18:18Z
• Authors: Qiang Yu; Zhili Guo; Xiaofeng Liu; Qing Ouyang; Cheng He; Geoffrey Burnstock; Hongbin Yuan; Zhenghua Xiang
• Keywords: Male; Neurons; 0303 health sciences; Purinergic P2X Receptor Antagonists; Apoptosis; Hippocampus; Rats; 3. Good health; Rats, Sprague-Dawley; 03 medical and health sciences; Neuroprotective Agents; Treatment Outcome; Ischemic Attack, Transient; Animals; Receptors, Purinergic P2X7

Transient global ischemia (which closely resembles clinical situations such as cardiac arrest, near drowning or severe systemic hypotension during surgical procedures), often induces delayed neuronal death in the brain, especially in the hippocampal CA1 region. The mechanism of ischemia/reperfusion (I/R) injury is not fully understood. In this study, we have shown that the P2X7 receptor antagonist, BBG, reduced delayed neuronal death in the hippocampal CA1 region after I/R injury; P2X7 receptor expression levels increased before delayed neuronal death after I/R injury; inhibition of the P2X7 receptor reduced I/R-induced microglial microvesicle-like components, IL-1β expression, P38 phosphorylation, and glial activation in hippocampal CA1 region after I/R injury. These results indicate that antagonism of the P2X7 receptor and signaling pathways of microglial MV shedding, such as src-protein tyrosine kinase, P38 MAP kinase and A-SMase, might be a promising therapeutic strategy for clinical treatment of transient global cerebral I/R injury.